Geode Capital Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.01M | Buy |
431,414
+8,192
| +2% | +$63.6K | ﹤0.01% | 2969 |
|
|
2025
Q4 | $2.99M | Buy |
423,222
+48,602
| +13% | +$375K | ﹤0.01% | 3013 |
|
|
2025
Q3 | $2.8M | Sell |
374,620
-27,089
| -7% | -$206K | ﹤0.01% | 3068 |
|
|
2025
Q2 | $2.95M | Buy |
401,709
+89,390
| +29% | +$780K | ﹤0.01% | 2999 |
|
|
2025
Q1 | $2.41M | Buy |
312,319
+8,221
| +3% | +$90.2K | ﹤0.01% | 2969 |
|
|
2024
Q4 | $3.68M | Buy |
304,098
+451
| +0.1% | +$5.77K | ﹤0.01% | 2891 |
|
|
2024
Q3 | $3.81M | Buy |
303,647
+43,840
| +17% | +$565K | ﹤0.01% | 2898 |
|
|
2024
Q2 | $3.1M | Buy |
259,807
+99,218
| +62% | +$1.36M | ﹤0.01% | 2967 |
|
|
2024
Q1 | $2.81M | Buy |
160,589
+26,164
| +19% | +$472K | ﹤0.01% | 2982 |
|
|
2023
Q4 | $3.45M | Buy |
134,425
+117,175
| +679% | +$1.66M | ﹤0.01% | 2882 |
|
|
2023
Q3 | $125K | Sell |
17,250
-752
| -4% | -$5.04K | ﹤0.01% | 4167 |
|
|
2023
Q2 | $94.9K | Hold |
18,002
| – | – | ﹤0.01% | 4351 |
|
|
2023
Q1 | $55.9K | Sell |
18,002
-18,610
| -51% | -$70.7K | ﹤0.01% | 4493 |
|
|
2022
Q4 | $144K | Sell |
36,612
-90
| -0.2% | -$367 | ﹤0.01% | 4249 |
|
|
2022
Q3 | $138K | Hold |
36,702
| – | – | ﹤0.01% | 4400 |
|
|
2022
Q2 | $489K | Sell |
36,702
-3,191
| -8% | -$21.2K | ﹤0.01% | 3779 |
|
|
2022
Q1 | $197K | Buy |
39,893
+1,682
| +4% | +$8.34K | ﹤0.01% | 4391 |
|
|
2021
Q4 | $261K | Sell |
38,211
-8,661
| -18% | -$148K | ﹤0.01% | 4361 |
|
|
2021
Q3 | $1.44M | Buy |
46,872
+2,541
| +6% | +$83.6K | ﹤0.01% | 3503 |
|
|
2021
Q2 | $1.44M | Sell |
44,331
-26,919
| -38% | -$924K | ﹤0.01% | 3423 |
|
|
2021
Q1 | $2.69M | Buy |
71,250
+28,940
| +68% | +$1.32M | ﹤0.01% | 3113 |
|
|
2020
Q4 | $2M | Buy |
42,310
+4,174
| +11% | +$181K | ﹤0.01% | 3084 |
|
|
2020
Q3 | $1.23M | Buy |
38,136
+5,815
| +18% | +$228K | ﹤0.01% | 3127 |
|
|
2020
Q2 | $1.42M | Buy |
32,321
+16,499
| +104% | +$775K | ﹤0.01% | 3020 |
|
|
2020
Q1 | $518K | Buy |
15,822
+1,610
| +11% | +$74K | ﹤0.01% | 3264 |
|
|
2019
Q4 | $725K | Hold |
14,212
| – | – | ﹤0.01% | 3388 |
|
|
2019
Q3 | $523K | Buy |
14,212
+1,826
| +15% | +$98.4K | ﹤0.01% | 3461 |
|
|
2019
Q2 | $684K | Sell |
12,386
-5,997
| -33% | -$375K | ﹤0.01% | 3349 |
|
|
2019
Q1 | $1.12M | Sell |
18,383
-840
| -4% | -$54K | ﹤0.01% | 3124 |
|
|
2018
Q4 | $1.14M | Buy |
19,223
+720
| +4% | +$53.1K | ﹤0.01% | 3050 |
|
|
2018
Q3 | $1.5M | Sell |
18,503
-3,755
| -17% | -$298K | ﹤0.01% | 3040 |
|
|
2018
Q2 | $1.95M | Buy |
22,258
+13,888
| +166% | +$2.44M | ﹤0.01% | 2875 |
|
|
2018
Q1 | $1.62M | Buy |
8,370
+4,663
| +126% | +$870K | ﹤0.01% | 2876 |
|
|
2017
Q4 | $379K | Buy |
+3,707
| New | +$189K | ﹤0.01% | 3462 |
|
|
2017
Q3 | – | Sell |
-1,658
| Closed | -$57K | – | 4062 |
|
|
2017
Q2 | $57K | Buy |
+1,658
| New | +$59.5K | ﹤0.01% | 3930 |
|
|
2017
Q1 | – | Sell |
-229
| Closed | -$16K | – | 4076 |
|
|
2016
Q4 | $16K | Buy |
229
+1
| +0.4% | +$90 | ﹤0.01% | 4015 |
|
|
2016
Q3 | $31K | Hold |
228
| – | – | ﹤0.01% | 3964 |
|
|
2016
Q2 | $39K | Hold |
228
| – | – | ﹤0.01% | 3961 |
|
|
2016
Q1 | $43 | Hold |
228
| – | – | ﹤0.01% | 3986 |
|
|
2015
Q4 | $80K | Hold |
228
| – | – | ﹤0.01% | 3932 |
|
|
2015
Q3 | $119K | Hold |
228
| – | – | ﹤0.01% | 3850 |
|
|
2015
Q2 | $500K | Hold |
228
| – | – | ﹤0.01% | 3198 |
|
|
2015
Q1 | $532K | Hold |
228
| – | – | ﹤0.01% | 3171 |
|
|
2014
Q4 | $471K | Buy |
228
+1
| +0.4% | +$1.93K | ﹤0.01% | 3217 |
|
|
2014
Q3 | $452K | Buy |
227
+6
| +3% | +$14.8K | ﹤0.01% | 3217 |
|
|
2014
Q2 | $783K | Sell |
221
-25
| -10% | -$81.6K | ﹤0.01% | 2941 |
|
|
2014
Q1 | $921K | Buy |
246
+5
| +2% | +$18.5K | ﹤0.01% | 2846 |
|
|
2013
Q4 | $788K | Hold |
241
| – | – | ﹤0.01% | 2862 |
|
|
2013
Q3 | $1.01M | Buy |
241
+11
| +5% | +$44.3K | ﹤0.01% | 2586 |
|
|
2013
Q2 | $774K | Buy |
+230
| New | +$875K | ﹤0.01% | 2614 |
|
Other funds holding GYRE
VCM
SS
VFT
VPM
Geode Capital Management's GYRE Position: Q1 2026 in Review
Geode Capital Management increased its Gyre Therapeutics (GYRE) stake by 1.9% in Q1 2026, buying an estimated $63.6K and bringing the position to 431,414 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2969.
Geode Capital Management first reported a position in GYRE in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.81M in Q3 2024. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.
- Geode Capital Management held 431,414 shares of Gyre Therapeutics worth $3.01M as of Q1 2026.
- Geode Capital Management bought 8,192 Gyre Therapeutics shares in Q1 2026, an estimated $63.6K.
- Gyre Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2969 holding.
- Geode Capital Management first reported a position in Gyre Therapeutics in Q2 2013 and has held it in 50 quarters since.
- Geode Capital Management's Gyre Therapeutics position peaked at $3.81M in Q3 2024.
- 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.